Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 39

Related Articles by Review for PubMed (Select 16750701)

1.

The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ.

J Am Coll Cardiol. 2006 Jun 6;47(11):2310-8. Epub 2006 May 4.

2.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

3.
4.

Cost-effectiveness of the implantable cardioverter defibrillator: a review of current evidence.

Lynd LD, O'Brien BJ.

J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S99-103. Review.

PMID:
12950529
6.

Economic outcomes of implantable cardioverter-defibrillators.

Stanton MS, Bell GK.

Circulation. 2000 Mar 7;101(9):1067-74. Review. Erratum in: Circulation 2000 Jun 20;101(24):2872.

7.

[Implantable defibrillators and prevention of sudden death: clinical and economic implications in the light of the MADIT II study].

Boriani G, Biffi M, Martignani C, Branzi A.

Monaldi Arch Chest Dis. 2002 Sep;58(2):145-50. Review. Italian.

PMID:
12418430
8.

Expanding indications for defibrillators after myocardial infarction: risk stratification and cost effectiveness.

Essebag V, Eisenberg MJ.

Card Electrophysiol Rev. 2003 Jan;7(1):43-8. Review.

PMID:
12766517
9.

Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?

Armoundas AA, Hohnloser SH, Ikeda T, Cohen RJ.

Nat Clin Pract Cardiovasc Med. 2005 Oct;2(10):522-8. Review.

PMID:
16186850
10.

The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis.

Smith T, Jordaens L, Theuns DA, van Dessel PF, Wilde AA, Hunink MG.

Eur Heart J. 2013 Jan;34(3):211-9. doi: 10.1093/eurheartj/ehs090. Epub 2012 May 14. Review.

11.

Implantable cardioverter-defibrillators: a new preventive medical option.

Glatter KA, Young JN, McElvany MD.

Prev Cardiol. 2006 Winter;9(1):49-53; quiz 54-5. Review.

PMID:
16407703
12.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

13.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

14.

Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.

McAlister FA, Ezekowitz J, Dryden DM, Hooton N, Vandermeer B, Friesen C, Spooner C, Rowe BH.

Evid Rep Technol Assess (Full Rep). 2007 Jun;(152):1-199. Review.

15.

Automatic implantable cardioverter defibrillator: cost effectiveness.

Hauer RN, Wever EF, Crijns HJ.

Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 2):559-63. Review.

PMID:
7681957
16.

Cardioverter-defibrillators after MADIT-II: the balance between weight of evidence and treatment costs.

Boriani G, Biffi M, Martignani C, Camanini C, Grigioni F, Rapezzi C, Branzi A.

Eur J Heart Fail. 2003 Aug;5(4):419-25. Review.

17.

MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate: risk stratification, costs, and public policy.

Reynolds MR, Josephson ME.

Circulation. 2003 Oct 14;108(15):1779-83. Review. No abstract available.

18.

Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic evaluation.

Bryant J, Brodin H, Loveman E, Clegg A.

Int J Technol Assess Health Care. 2007 Winter;23(1):63-70. Review.

PMID:
17234018
20.

Hormonal therapies for early breast cancer: systematic review and economic evaluation.

Hind D, Ward S, De Nigris E, Simpson E, Carroll C, Wyld L.

Health Technol Assess. 2007 Jul;11(26):iii-iv, ix-xi, 1-134. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk